Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Therapeutic cancer vaccine targeted to HAAH (aspartyl-[asparaginyl]-beta-hydroxylase

Therapeutic cancer vaccine targeted to HAAH (aspartyl-[asparaginyl]-beta-hydroxylase

US Patent 10702591 · Granted Jul 7, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Bacteriophage compositions and methods of selection of components against specif2025
Method for purification of bacteriophage particles2024
Phage dispensing system2024
Bacteriophage-based vaccines and engineered bacteriophage2023
Fibrous nerve conduit for promoting nerve regeneration2022
Treatment for chemotherapy-induced cognitive impairment2020
Treatment for chemotherapy-induced peripheral neuropathy2020
Bacteriophage compositions and methods of selection of components against specif2019
System and method for enhanced emulation of connected vehicle applications2019
Radio-imaging and radio-therapy of cancer using antibodies to HAAH2019
Therapeutic cancer vaccine targeted to HAAH (aspartyl-[asparaginyl]-β-hydroxylas2017
Therapeutic cancer vaccine targeted to HAAH (aspartyl-[asparaginyl]-β-hydroxylas2017